MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 58 filers reported holding MIRATI THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,840,800 | +171.3% | 180,000 | +125.0% | 1.11% | +159.6% |
| Q2 2023 | $2,890,400 | +6.3% | 80,000 | +33.3% | 0.43% | +7.8% |
| Q4 2022 | $2,718,600 | +94.6% | 60,000 | +200.0% | 0.40% | +131.0% |
| Q3 2022 | $1,397,000 | -87.7% | 20,000 | -94.9% | 0.17% | -97.2% |
| Q1 2015 | $11,392,000 | +158.0% | 388,543 | +63.0% | 6.06% | +150.3% |
| Q4 2014 | $4,416,000 | -12.6% | 238,432 | -17.3% | 2.42% | -7.5% |
| Q3 2014 | $5,050,000 | -12.5% | 288,432 | 0.0% | 2.62% | -2.1% |
| Q2 2014 | $5,769,000 | -30.6% | 288,432 | -33.8% | 2.67% | -33.7% |
| Q1 2014 | $8,312,000 | -46.7% | 435,843 | -53.6% | 4.03% | -63.1% |
| Q4 2013 | $15,608,000 | -12.8% | 938,543 | -20.6% | 10.92% | +23.2% |
| Q3 2013 | $17,898,000 | – | 1,181,400 | – | 8.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |